Henri Huttunen, Herantis Pharma

In this episode of Careers in Discovery, Emma sits down with Henri Huttunen, Chief Scientific Officer at Herantis Pharma, a Finnish biotech developing ground-breaking therapies for Parkinson’s and related neurodegenerative diseases. Henri shares the exciting progress on their next-generation molecule that crosses the blood-brain barrier and their innovative approach to tackling the challenges of clinical trials in this field. Henri reflects on his journey, from his early days in academic research to founding start-ups and leading Herantis’ mission to develop disease-modifying treatments. He talks about the importance of balancing scientific rigour with innovation, navigating the risks of challenging established dogmas, and the role personal passion plays in driving success. This episode is packed with insights into the cutting edge of neurodegenerative research, the lessons learned from taking bold career steps, and the inspiration behind Henri’s dedication to improving patients’ lives. Tune in for an inspiring and thought-provoking conversation.